<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03887949</url>
  </required_header>
  <id_info>
    <org_study_id>2017-I013</org_study_id>
    <nct_id>NCT03887949</nct_id>
  </id_info>
  <brief_title>Comparison of Three Modes of Ventilation During Robot-assisted Hysterectomy in Trendelenburg Position</brief_title>
  <official_title>Comparison of Three Modes of Ventilation During Robot-assisted Hysterectomy in Trendelenburg Position: Volume Controlled Ventilation, Pressure Controlled Ventilation, and Pressure Controlled Ventilation With Volume Guarantee.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hallym University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hallym University Medical Center</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Robot-assisted hysterectomy is associated with pneumoperioneum with CO2 and Trendelenburg
      position, which may have adverse cardiopulmonary effects. A new ventilation mode;
      pressure-controlled ventilation with volume guaranteed mode (PCV-VG) delivers constant tidal
      volume with constant inspiratory pressure, using a decelerating flow pattern. This
      prospective, randomized study is designed to compare the effects of PCV-VG, volume-controlled
      ventilation (VCV) and pressure-controlled ventilation (PCV) on respiratory and hemodynamic
      variables in patients undergoing Robot-assisted hysterectomy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. Total 60 patients with American Society of Anesthesiologists physical status I-II who
           underwent Robot-assisted hysterectomy were enrolled.

        2. All patients were fasted for 8 hours before the surgery and were premedicated with
           intramuscular glycopyrrolate 0.2 mg. Anesthesia was induced with intravenous
           remifentanil (0.1-0.2 ug/kg/min), propofol (1.5-2 mg/kg) and rocuronium (0.6 mg/kg) and
           maintained with sevoflurane (2.0-2.5 vol%) in inspired oxygen fraction with 0.5,
           remifentanil (0.05-0.3 ug/kg/min) and vecuronium (0.03-0.05 mg/kg/hr).

        3. A 20 G catheter was inserted into the radial artery to monitor continuous arterial
           pressure and hemodynamic variables (cardiac output, cardiac index, stroke volume, stroke
           volume index, and stroke volume variation) monitoring.

        4. All patients were ventilated with a Datex-Ohmeda Ventilator (S/5 AVANCE). Patients were
           randomized to receive VCV (n=20), PCV (n=20), or PCV-VG (n=20) mode. The tidal volume
           was set to deliver 8 mL/kg of ideal body weight. The respiratory rate(RR) was adjust to
           maintain end tidal CO2 (ETCO2) 32-37 mmHg.

        5. Hemodynamic variables (mean blood pressure, heart rate, cardiac output, cardiac index,
           stroke volume, stroke volume index, and stroke volume variation) , respiratory variables
           (saturation, RR, ETCO2, peak airway pressure, mean airway pressure and lung dynamic
           compliance) and arterial gas analyses were recorded at 4 stages: (1) 15 minutes after
           induction in supine position, (2) 30 minutes after pneumoperitoneum and Trendelenburg
           position, (3) 60 minutes after pneumoperitoneum and Trendelenburg position, (4) 15
           minutes after pneumoperitoneum withdrawal in supine position.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 1, 2018</start_date>
  <completion_date type="Anticipated">May 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Peak airway pressure</measure>
    <time_frame>2-3 hours through the surgery</time_frame>
    <description>The highest level of pressure applied to the lung during inhalation</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>VCV</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Volume controlled ventilation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PCV</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Pressure controlled ventilation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PCV-VG</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Pressure controlled ventilation with volume guarantee</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Group VCV</intervention_name>
    <description>Volume controlled ventilation</description>
    <arm_group_label>VCV</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Group PCV</intervention_name>
    <description>Pressure controlled ventilation</description>
    <arm_group_label>PCV</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Group PCV-VG</intervention_name>
    <description>Pressure controlled ventilation with volume guarantee</description>
    <arm_group_label>PCV-VG</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who were scheduled for Robot-assisted hysterectomy

          -  American Society of Anesthesiologists physical status I-II

        Exclusion Criteria:

          -  Age under 20 years old or over 65 years old

          -  Body mass index &gt; 30 kg/m2

          -  Systolic blood pressure &lt; 100 mmHg

          -  Heart rate &lt; 60 bpm

          -  Uncompensated cardiac disease

          -  FEV1 &lt; 60%

          -  Hypoxemia (PaO2 &lt; 60 mmHg or oxygen saturation &lt; 90%)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eun Young Park, MD</last_name>
    <role>Study Director</role>
    <affiliation>Hallym Univesity Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jung Min Lee, MD</last_name>
    <phone>+82-31-380-3843</phone>
    <phone_ext>3943</phone_ext>
    <email>vanilla228@hanmail.net</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Eun Young Park, MD</last_name>
    <phone>+82-31-380-3953</phone>
    <phone_ext>3953</phone_ext>
    <email>parkey@hallym.or.kr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hallym University Sacred Heart Hospital</name>
      <address>
        <city>Anyang-si</city>
        <state>Dongan-gu</state>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eun Young Park, MD</last_name>
      <phone>+81-31-380-3953</phone>
      <email>parkey00@hallym.or.kr</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <reference>
    <citation>Assad OM, El Sayed AA, Khalil MA. Comparison of volume-controlled ventilation and pressure-controlled ventilation volume guaranteed during laparoscopic surgery in Trendelenburg position. J Clin Anesth. 2016 Nov;34:55-61. doi: 10.1016/j.jclinane.2016.03.053. Epub 2016 May 2.</citation>
    <PMID>27687346</PMID>
  </reference>
  <reference>
    <citation>Dion JM, McKee C, Tobias JD, Sohner P, Herz D, Teich S, Rice J, Barry ND, Michalsky M. Ventilation during laparoscopic-assisted bariatric surgery: volume-controlled, pressure-controlled or volume-guaranteed pressure-regulated modes. Int J Clin Exp Med. 2014 Aug 15;7(8):2242-7. eCollection 2014.</citation>
    <PMID>25232415</PMID>
  </reference>
  <reference>
    <citation>Pu J, Liu Z, Yang L, Wang Y, Jiang J. Applications of pressure control ventilation volume guaranteed during one-lung ventilation in thoracic surgery. Int J Clin Exp Med. 2014 Apr 15;7(4):1094-8. eCollection 2014.</citation>
    <PMID>24955188</PMID>
  </reference>
  <reference>
    <citation>Oğurlu M, Küçük M, Bilgin F, Sizlan A, Yanarateş O, Eksert S, Karaşahin E, Coşar A. Pressure-controlled vs volume-controlled ventilation during laparoscopic gynecologic surgery. J Minim Invasive Gynecol. 2010 May-Jun;17(3):295-300. doi: 10.1016/j.jmig.2009.10.007. Epub 2010 Mar 19.</citation>
    <PMID>20303833</PMID>
  </reference>
  <reference>
    <citation>Kim MS, Soh S, Kim SY, Song MS, Park JH. Comparisons of Pressure-controlled Ventilation with Volume Guarantee and Volume-controlled 1:1 Equal Ratio Ventilation on Oxygenation and Respiratory Mechanics during Robot-assisted Laparoscopic Radical Prostatectomy: a Randomized-controlled Trial. Int J Med Sci. 2018 Oct 20;15(13):1522-1529. doi: 10.7150/ijms.28442. eCollection 2018.</citation>
    <PMID>30443174</PMID>
  </reference>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>March 21, 2019</study_first_submitted>
  <study_first_submitted_qc>March 21, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 25, 2019</study_first_posted>
  <last_update_submitted>March 21, 2019</last_update_submitted>
  <last_update_submitted_qc>March 21, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 25, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hallym University Medical Center</investigator_affiliation>
    <investigator_full_name>Eun Young Park</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

